The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $153.
ConocoPhillips
COP · a US exchange · USD · Market cap $160.3B · 9,700 employees
ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG), and natural gas liquids.
PASS · Titan Ethical · score 88.5Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price134.99 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 17 Nov 2026
- Ethical screenPasses, score 88.5 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.47)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $116.10 to $141.04, base estimate $122.64 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.47, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
ConocoPhillips holds its Distribution at $134.99. Consolidating, no directional conviction, held for 381 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 381 days |
| Price at the screen | $134.99 |
| Valuation | 14.29 trailing · 12.03 forward price to earnings |
| Values screen | PASS · score 88.5 |
| Beta | 0.16 |
Five Screens: COP's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 19.23% | Below 33% | Pass |
| Interest-bearing cash | 0.94% | Below 33% | Pass |
| Receivables | 10.10% | Below 49% | Pass |
| Revenue purity | 0.53% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
ConocoPhillips clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 19%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when COP's ethical verdict changes
Today COP passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades above our $122.64 fair value estimate, moderate competitive moat, 29.30% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 10.1% above the base estimate.
Third-party analyst targets: 27 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $122.64, with a range of $116.10 to $141.04, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 12.0xcheap for a company growing this fast |
| Trailing P/E | 14.3xreasonably valued |
| EPS, trailing | 9.49 |
| EPS, forward | 11.28 |
| Revenue growth | +29.3%strong top-line growth |
| Profit margin | 16.8%healthy profit margins |
| Return on equity | 17.7%a solid return on shareholder capital |
| FCF yield | 7.15% |
| Dividend yield | 2.67% |
| Debt to equity | 0.35minimal debt: a conservative balance sheet |
| Current ratio | 1.52healthy short-term liquidity |
| Beta | 0.16barely tracks the market's swings |
| Short interest, float | 0.02% |
| 52-week range | 85.70 - 154.28 |
| Moat | MODERATE |
| Market cap | $160.3B |
| Employees | 9,700 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. Since the last review it its composite score rose.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (26 analysts) rates it buy, with a mean price target of $142. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Your Chevron Hedge Works Only While Oil Spikes Yahoo Finance · 18h ago
- Crude Gives Back Ground Midweek as Inventories Build and Surplus Talk Grows Yahoo Finance · 19h ago
- Should You Buy Occidental Stock For Its Cash Flow? Yahoo Finance · 22h ago
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater Yahoo Finance · 2d ago
- Learn Why The Bull Case For ConocoPhillips Stock Could Change Following Earnings And Dividend Hike Yahoo Finance · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | MCRAVEN WILLIAM H. | Director | 2,230 | · | |
| 2026-04-15 | LEACH TIMOTHY ALLEN | Director | 2,230 | · | |
| 2026-03-31 | LANCE RYAN MICHAEL | Chief Executive Officer | 113,221 | $15,025,389 | |
| 2026-03-31 | OLDS NICHOLAS G | Officer | 1,903 | · | |
| 2026-03-24 | ROSE KELLY BRUNETTI | General Counsel | 7,700 | $1,001,212 | |
| 2026-03-23 | OLDS NICHOLAS G | Officer | 6,994 | $888,651 | |
| 2026-03-20 | LANCE RYAN MICHAEL | Chief Executive Officer | 506,800 | $64,493,594 | |
| 2026-03-20 | LANCE RYAN MICHAEL | Chief Executive Officer | 506,800 | $25,215,834 | |
| 2026-03-13 | HRAP HEATHER G. | Officer | 2,654 | $317,631 | |
| 2026-03-13 | LUNDQUIST ANDREW D | Officer | 34,500 | $4,128,960 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-26 | Michael McCaul | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $115.55 | +4.3% | $0.84 | $1,050 | +5.0% |
| 2 months | $121.65 | -0.9% | $0.84 | $998 | -0.2% |
| 3 months | $119.37 | +1.0% | $0.84 | $1,017 | +1.7% |
| 6 months | $95.26 | +26.5% | $1.68 | $1,283 | +28.3% |
| 1 year | $88.25 | +36.6% | $3.30 | $1,403 | +40.3% |
| 2 years | $106.35 | +13.3% | $6.42 | $1,194 | +19.4% |
| 3 years | $94.27 | +27.9% | $10.27 | $1,387 | +38.7% |
| 5 years | $50.18 | +140.2% | $17.97 | $2,760 | +176.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever COP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.